MedPath

Taiwan Geriatric Study for Dementia Risk Prevention and Cognitive Enhancement by Multi-modal Intervention

Not Applicable
Recruiting
Conditions
Dementia
Interventions
Behavioral: multi-modal non-pharmacological intervention
Registration Number
NCT05407857
Lead Sponsor
Taipei Medical University Shuang Ho Hospital
Brief Summary

A 3-arm randomized controlled trial of multi-modal non-pharmacological Intervention for preventing the risk of dementia in Taiwanese geriatric people

Detailed Description

This project proposes an intervention program for dementia prevention based on the Taiwanese model. The investigator(s) will screen the elderly who are not yet demented but are at high risk of dementia and will randomly allocate them into three groups (on site intervention group, remote intervention group, and control group) for a two-year multi-modal non-pharmacological intervention. All intervention groups will be actively involved in management with nutrition, exercise and cognitive programs. The on-site intervention group requires subjects to participate in prescribed place according to the protocol. The remote intervention group is designed for reducing the chances of person-to-person contact response to the current coronavirus disease 2019 (COVID-19) pandemic and development of digital internet. It uses innovative technology combining wearable devices with inertial measurement units, blue-tooth equipment, apps, feedback technology and artificial intelligence based remote comprehensive training programs. During the study period, each group will be regularly monitored the changes of cardiovascular risk factors, physical performance and cognitive function. The results of multimodal intervention mainly from Taipei and New Taipei City will establish the Taiwan FINGER model (TaiPEI) and will have the information of the conditions and feasibility achieved in Taiwan and implementation suggestions in the face of the epidemic. It can be subsequently applied to the brain/body health care institution and to the prevention of dementia and cardiovascular disease of elderly.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
380
Inclusion Criteria
  1. People over 60 without dementia
  2. Agree to join the study and sign the consent form
  3. The Modified Rankin Scale (MRS) scores between 0-1 points
  4. Education level: elementary or higher education (6 years) or can read and write Chinese
  5. Very early dementia screening scale (AD-8) < 2, or more than 2 points but without dementia diagnoses after refer to a neurologist.
  6. Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) Risk Score: above 8; diagnosed with mild cognitive impairment (MCI) or subjective cognitive decline (SCD) in the past six months.
Exclusion Criteria
  1. Have been diagnosed with any kind of dementia
  2. Suspected dementia patients or others who are not suitable to participate in the research assessed by a doctor at the first visit
  3. Diseases affecting the safety of various interventional activities (such as remaining life less than two years, symptomatic heart/cerebrovascular disease within 6 months, vascular reperfusion or reconstruction-related surgery within one year, etc., malignant tumor within one year)
  4. Severe blindness, hearing or communication impairment, or other difficulty in cooperating or completing assessments and interventions (especially exercise) in the study
  5. Severe mental illnesses, including major depression disorder, or major neuromusculoskeletal disorders that are not suitable to join the study.
  6. Drug or alcohol abuse in the last year
  7. Overlapping with other interventional trials at the same time which may affect the evaluation results.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Controlmulti-modal non-pharmacological interventionThe control group will also receive the same health evaluation and education as all intervention groups.
On-sitemulti-modal non-pharmacological interventionThe on-site multi-modal intervention will be actively involved in management with nutrition, exercise and cognitive programs. The on-site intervention group requires subjects to participate in prescribed place according to the protocol.
Remotemulti-modal non-pharmacological interventionThe remote intervention group is designed for reducing the chances of person-to-person contact response to the current COVID-19 pandemic and development of digital internet. It uses innovative technology combining wearable devices with inertial measurement units, blue-tooth equipment, apps, feedback technology and artificial intelligence based remote comprehensive training programs.
Primary Outcome Measures
NameTimeMethod
Change in cognition including individual cognitive domains, unit on a scaleBefore intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)

A composite z-score will be obtained from the neuropsychological tests evaluating multiple cognitive domains, including memory, language, process speed, visuospatial, and executive function.

Secondary Outcome Measures
NameTimeMethod
Change of nutrition intake, unit on a scaleBefore intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)

3-day dietary record: a self-reported account of all foods and beverages consumed within recent three days

Change in physical assessment, unit on a scaleBefore intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)

International Physical Activity Questionnaire (IPAQ), a 27-item self-reported measure of physical activity

Change in physical functioning - Hand-grip strength, kgBefore intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)

Measured using a hand-grip dynamometer

Change in functioning level, unit on a scaleBefore intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)

Activities of Daily Living Questionnaire (ADLQ), The Brief University of California San Diego (UCSD) Performance-Based Skills Assessment(Traditional Chinese Version)(UPSA-Brief), Florida Cognitive Activities Scale(FCAS), EuroQol five-dimensional (EQ-5D)

Change of the questionnaire regarding the nutrition, unit on a scaleBefore intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)

food frequency questionnaire (FFQ), a finite list of foods and beverages with response categories to indicate usual frequency of consumption over the time period

Change in blood tests - fasting plasma glucose, mmol/L.Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)

Measured from fasting blood sample

Change of Plasma amyloid beta, pg/mLBefore intervention (Baseline); During intervention (6th month and 24th month)

Assessed by ultra-sensitive, immunomagnetic reduction assay (MagQu, LLC, Surprise, AZ),

Change of Plasma tau, pg/mLBefore intervention (Baseline); During intervention (6th month and 24th month)

Assessed by ultra-sensitive, immunomagnetic reduction assay (MagQu, LLC, Surprise, AZ),

Change in sleep symptoms, unit on a scale.Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)

Pittsburgh Sleep Quality Index (PSQI)

Change in depressive symptoms, unit on a scale.Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)

Geriatric Depression Scale-Short Form (GDS-S), score range: 0-15; higher scores mean a worse outcome.

Change in blood tests - triglycerides, mmol/L.Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)

Measured from fasting blood sample

Change in blood tests - Albumin, prealbumin, g/dL.Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)

Measured from fasting blood sample

Trial Locations

Locations (1)

Taipei Medical University-Shuang Ho Hospital

🇨🇳

New Taipei City, Taiwan

© Copyright 2025. All Rights Reserved by MedPath